RUCONEST® (C1 esterase inhibitor [recombinant]) A Recombinant C1INH Treatment Option
Sunday, March 6, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon E
0.00 CME/CE
This program is not sponsored or programmed by the AAAAI.
Sponsored by Salix Pharmaceuticals.
Presenter:
Marc Riedl, MD
Professor of Medicine
Clinical Director – US HAEA Angioedema Center
Division of Rheumatology, Allergy and Immunology
University of California
San Diego, California
See more of: Non-CME Educational Programs